102.25
-2.10
(-2.01%)
At close: January 31 at 9:34:16 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-132,570.00
-145,080.00
-116,511.00
-108,226.00
-78,456.57
Investing Cash Flow
-247.00
-582.00
-53,702.00
-308.00
-45.89
Financing Cash Flow
43,594.00
331,013.00
284,582.00
11,130.00
42,412.75
End Cash Position
327,341.00
386,193.00
200,842.00
86,473.00
183,876.45
Interest Paid Supplemental Data
19,803.00
16,730.00
7,686.00
4,625.00
2,097.29
Capital Expenditure
-247.00
-582.00
-702.00
-308.00
-45.89
Issuance of Capital Stock
24,365.00
258,750.00
243,763.00
7,436.00
14,125.51
Issuance of Debt
--
85,000.00
45,000.00
--
50,000.00
Repayment of Debt
--
--
--
--
-21,660.00
Free Cash Flow
-132,817.00
-145,662.00
-117,213.00
-108,534.00
-78,502.46
12/31/2020 - 8/28/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
12X1.F Anavex Life Sciences Corp.
9.11
-0.87%
TRRI Alzex Neuropharma Inc.
0.1980
0.00%
IBIO iBio, Inc.
3.0100
+1.35%
JAGX Jaguar Health, Inc.
0.8844
-1.73%
VXRT Vaxart, Inc.
0.6798
-4.92%
OCGN Ocugen, Inc.
0.7274
-5.43%
SLXN Silexion Therapeutics Corp
1.9000
-7.32%
TNXP Tonix Pharmaceuticals Holding Corp.
0.4281
+14.16%